Patents by Inventor Deborah Meshulam

Deborah Meshulam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170002393
    Abstract: Compositions and methods for minimizing antibody disulfide bond reduction are described. In one aspect, a composition is provided for culturing mammalian host cells to express an antibody including an anti-reduction agent that minimizes reduction of a disulfide bond in the antibody or fragment thereof. In some other aspects, methods for minimizing disulfide bond reduction; increasing production of an antibody or fragment thereof with intact native disulfide bonds; increasing a ratio of non-reduced to reduced antibody or fragment thereof; producing a therapeutic antibody or fragment thereof by adding a sufficient amount of an anti-reduction agent to a cell culture media, pre-harvest cell culture fluid, or harvest cell culture fluid are described. In another aspect, minimizing disulfide bond reduction in an antibody or fragment thereof culturing the host cell in a concentration of at least about 20% O2 is described.
    Type: Application
    Filed: December 3, 2014
    Publication date: January 5, 2017
    Applicant: IMMUNOGEN, INC.
    Inventors: RAJEEVA SINGH, NATHAN FISHKIN, SETH KITCHENER, DEBORAH MESHULAM
  • Publication number: 20110166319
    Abstract: The invention provides processes for preparing a cell-binding agent chemically coupled to a drug. A first process comprises covalently attaching a linker to a cell-binding agent, an optional purification step, conjugating a drug to the cell-binding agent, a subsequent purification step, and optional holding steps. A second process comprises covalently attaching a linker to a cell-binding agent, a purification step, conjugating a drug to the cell-binding agent, a subsequent purification step, holding steps, and optionally a tangential flow filtration (TFF) step.
    Type: Application
    Filed: December 22, 2010
    Publication date: July 7, 2011
    Applicant: ImmunoGen, Inc.
    Inventors: Yong DAI, Yong WANG, Shengjin JIN, Deborah MESHULAM, Godfrey AMPHLETT, Ravi CHARI, Wei ZHANG
  • Publication number: 20070048314
    Abstract: The invention provides a process for preparing a cell-binding agent chemically coupled to a drug. The process comprises covalently attaching a linker to a cell-binding agent, a purification step, conjugating a drug to the cell-binding agent and a subsequent purification step.
    Type: Application
    Filed: August 14, 2006
    Publication date: March 1, 2007
    Applicant: ImmunoGen, Inc.
    Inventors: Yong Dai, Yong Wang, Shengjin Jin, Deborah Meshulam, Godfrey Amphlett
  • Publication number: 20060182750
    Abstract: The invention provides a process for preparing a conjugate comprising a cell binding agent chemically coupled to a drug. The process comprises covalently attaching a linker to a cell binding agent, which then is conjugated to a drug, as well as purification and holding steps, and optionally a tangential flow filtration (TFF) step.
    Type: Application
    Filed: February 10, 2006
    Publication date: August 17, 2006
    Applicant: ImmunoGen, Inc.
    Inventors: Ravi Chari, Wei Zhang, Deborah Meshulam, Yong Dai, Yong Wang, Godfrey Amphlett